Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of methimazole on itopride pharmacokinetics in healthy male volunteers
ChiCTR-TNRC-11001183Phase 4Completed
- Sponsor
- Pharmacogenetics Research Institute, Xiangya Hospital, Central South University
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methimazole and itopride (2 arms), sponsored by Pharmacogenetics Research Institute, Xiangya Hospital, Central South University. Primary endpoints: AUC0-inf of itopride, Cmax of itopride and 1 more. Started Jan 2009; status: completed.
02
Drugs
methimazoleitopride
Beyond the preview
Go deeper on ChiCTR-TNRC-11001183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNRC-11001183.